Safety and Immunogenicity of RH5.1/Matrix-M in Adults and Infants Living in Tanzania
NCT04318002
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Malaria,Falciparum
Interventions
BIOLOGICAL:
RH5.1/Matrix-M
Sponsor
University of Oxford
Collaborators
[object Object]
[object Object]